^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SLC-3010

i
Other names: SLC-3010
Associations
Trials
Company:
Selecxine
Drug class:
CD8 T-cell agonist, IL-2 inhibitor
Associations
Trials